COLOMBA, PAOLO
 Distribuzione geografica
Continente #
AS - Asia 1.684
NA - Nord America 1.145
EU - Europa 618
SA - Sud America 302
AF - Africa 36
OC - Oceania 7
Totale 3.792
Nazione #
US - Stati Uniti d'America 1.092
SG - Singapore 677
CN - Cina 387
BR - Brasile 242
IT - Italia 237
VN - Vietnam 184
HK - Hong Kong 164
FR - Francia 100
NL - Olanda 81
BD - Bangladesh 68
DE - Germania 50
GB - Regno Unito 47
KR - Corea 46
JP - Giappone 34
FI - Finlandia 32
IN - India 31
CA - Canada 29
AR - Argentina 22
TR - Turchia 16
MX - Messico 15
PL - Polonia 14
IQ - Iraq 10
ZA - Sudafrica 10
CO - Colombia 9
SA - Arabia Saudita 9
SE - Svezia 9
ES - Italia 8
AU - Australia 7
EC - Ecuador 7
EG - Egitto 7
PY - Paraguay 7
ID - Indonesia 6
IL - Israele 6
TN - Tunisia 6
PH - Filippine 5
AE - Emirati Arabi Uniti 4
BO - Bolivia 4
LT - Lituania 4
PE - Perù 4
UZ - Uzbekistan 4
AT - Austria 3
AZ - Azerbaigian 3
CZ - Repubblica Ceca 3
GT - Guatemala 3
IE - Irlanda 3
JO - Giordania 3
KZ - Kazakistan 3
LB - Libano 3
MA - Marocco 3
PK - Pakistan 3
RU - Federazione Russa 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
UA - Ucraina 3
VE - Venezuela 3
AL - Albania 2
BG - Bulgaria 2
CL - Cile 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GR - Grecia 2
KE - Kenya 2
KW - Kuwait 2
MY - Malesia 2
NP - Nepal 2
TW - Taiwan 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
BE - Belgio 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
LS - Lesotho 1
LV - Lettonia 1
MD - Moldavia 1
MM - Myanmar 1
MN - Mongolia 1
PA - Panama 1
PT - Portogallo 1
RO - Romania 1
SN - Senegal 1
SZ - Regno dello Swaziland 1
TZ - Tanzania 1
Totale 3.792
Città #
Singapore 410
Santa Clara 386
Hong Kong 159
San Jose 147
Hefei 121
Ashburn 95
Beijing 78
Lauterbourg 75
Los Angeles 68
Ho Chi Minh City 62
Hanoi 46
Seoul 44
Dallas 43
Tokyo 26
Frankfurt am Main 24
São Paulo 21
New York 20
Council Bluffs 18
Lappeenranta 18
Rome 17
Buffalo 16
Guangzhou 15
Naples 14
Helsinki 13
Orem 12
London 11
Milan 11
Palermo 11
Rio de Janeiro 11
Düsseldorf 9
Da Nang 8
Mexico City 8
Stockholm 8
Warsaw 8
Elk Grove Village 7
Haiphong 7
Hyderabad 7
Ankara 6
Belo Horizonte 6
Brasília 6
Cairo 6
Charlotte 6
Chennai 6
Houston 6
Minamishinagawa 6
Montreal 6
Munich 6
Riyadh 6
Toronto 6
Bengaluru 5
Biên Hòa 5
Curitiba 5
Padua 5
Phoenix 5
Portsmouth 5
Ribeirão Preto 5
San Francisco 5
Sydney 5
Turin 5
Atlanta 4
Bologna 4
Cagliari 4
Florence 4
Hải Dương 4
Johannesburg 4
Lima 4
Paris 4
Redondo Beach 4
Tashkent 4
Vancouver 4
Wroclaw 4
Amman 3
Asunción 3
Baghdad 3
Baku 3
Bari 3
Birmingham 3
Brooklyn 3
Campinas 3
Casalnuovo di Napoli 3
City of London 3
Guatemala City 3
Guayaquil 3
Istanbul 3
Manchester 3
Medellín 3
Natal 3
New Delhi 3
Newark 3
Ottawa 3
Poplar 3
Quito 3
São Bernardo do Campo 3
Vitória da Conquista 3
Vũng Tàu 3
Almaty 2
Andria 2
Anápolis 2
Bangkok 2
Basra 2
Totale 2.306
Nome #
Sex Differences in Anderson-Fabry Cardiomyopathy: Clinical, Genetic, and Imaging Analysis in Women 116
Expanded screening for Fabry disease in patients with chronic kidney disease not on dialysis: a multicenter Italian experience 106
miR-126-3p and miR-21-5p as Hallmarks of Bio-Positive Ageing; Correlation Analysis and Machine Learning Prediction in Young to Ultra-Centenarian Sicilian Population 102
Highlights of Precision Medicine, Genetics, Epigenetics and Artificial Intelligence in Pompe Disease 92
Molecular and clinical studies in five index cases with novel mutations in the GLA gene. 82
Can Be miR-126-3p a Biomarker of Premature Aging? An Ex Vivo and In Vitro Study in Fabry Disease 80
Diagnosis of Fabry Disease Using Alpha-Galactosidase A Activity or LysoGb3 in Blood Fails to Identify Up to Two Thirds of Female Patients 80
Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease? 77
Pompe disease: pathogenesis, molecular genetics and diagnosis 73
Halloysite Nanotubes and Sepiolite for Health Applications 70
A novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema 68
Hemochromatosis Mimicked Gaucher Disease: Role of Hyperferritinemia in Evaluation of a Clinical Case 68
Calnexin is down-regulated in Fabry disease. A possible implication in protein misfolding 66
The Identification of a Novel Pathogenic Variant of the GLA Gene Associated with a Classic Phenotype of Anderson–Fabry Disease: A Clinical and Molecular Study 66
Late-Onset Pompe Disease with Normal Creatine Kinase Levels: The Importance of Rheumatological Suspicion 66
Identification of Four New Mutations in the GLA Gene Associated with Anderson–Fabry Disease 66
Fabry Disease and Inflammation: Potential Role of p65 iso5, an Isoform of the NF-κB Complex 65
Mutation Spectrum of GAA Gene in Pompe Disease: Current Knowledge and Results of an Italian Study 65
Novel Pathogenic Variant of Fabry Disease in a Family with Parapelvic Cysts 63
Systematic DNA Study for Fabry Disease in the End Stage Renal Disease Patients from a Southern Italy Area 62
Gaucher Disease or Acid Sphingomyelinase Deficiency? The Importance of Differential Diagnosis 62
Nanomaterials: A Review about Halloysite Nanotubes, Properties, and Application in the Biological Field 61
A classical phenotype of Anderson-Fabry disease in a female patient with intronic mutations of the GLA gene: a case report 61
De novo mutation in a male patient with Fabry disease: a case report 58
Up-regulation of gamma-enolase in PMC from Fabry patients 57
Identification of Novel Mutations in Patients Affected by Gaucher Disease 57
A pilot study of circulating microRNAs as potential biomarkers of Fabry disease 54
European Biotech week 53
Prevalence of GLA gene mutations and polymorphisms in patients with multiple sclerosis: A cross-sectional study 53
Cytokines gene expression in the tunica albuginea in patients with Peyronie's disease. Pilot study with a control group 52
Misdiagnosi di Febbre Mediterranea Familiare in pazienti con Malattia di Anderson-Fabry 52
Fabry disease, a complex pathology not easy to diagnose 52
The Phenotypic Characterization of the Cammalleri Sisters, an Example of Exceptional Longevity 50
Diagnosing Fabry nephropathy: the challenge of multiple kidney disease 49
Role of S128R polymorphism of E-selectin in colon metastasis formation 48
Alteration of proteomic profiles in PBMC isolated from patients with Fabry disease: preliminary findings 48
Case report: De novo mutation of a-galactosidase A in a female patient with end-stage renal disease: report of a case of late diagnosis of Anderson–Fabry disease 47
Fabry disease and multiple sclerosis misdiagnosis: the role of family history and neurological signs. 45
Fabry disease: a proteomic approach 43
High variability of fabry disease manifestations in an extended italian family 42
Proteomic approach in Fabry disease: a case report 41
Novel alpha-galactosidase A mutation in patients with severe cardiac manifestations of Fabry disease 40
Fabry Disease Beyond Storage: The Role of Inflammation in Disease Progression 40
Identification of a novel mutation in the alpha-galactosidase A gene in patients with Fabry disease 39
Misdiagnosis of familial Mediterranean fever in patients with Anderson-Fabry disease 38
Alterazioni introniche in soggetti con sintomatologia riconducibile alla malattia di Fabry 37
Effects of different RAS mutations on colorectal cancer cells 36
Mucopolysaccharidosis Type I and α-Mannosidosis—Phenotypically Comparable but Genetically Different: Diagnostic and Therapeutic Considerations 35
Two distinct amplification events of the c-myc locus in a colorectal tumour 34
A family with various symptomatology suggestive of Anderson-Fabry disease and a genetic polymorphism of alpha galactosidase A gene 34
Effects of different RAS mutations on colorectal cancer cells 34
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease 34
Multiplex Ligation Probe Amplification and Sanger Sequencing: Light and Shade in the Diagnosis of Lysosomal Storage Disorders 33
Possible relation between genetic recombination and amplification within the c-myc locus in a case of primary colorectal carcinoma 32
Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture and metastasis 31
VEXAS Syndrome: Genetics, Gender Differences, Clinical Insights, Diagnostic Pitfalls, and Emerging Therapies 30
Ruolo di H-RAS e K-RAS nell'espressione di mucine nel carcinoma colorettale 29
Response to Simsek et al. 28
Intrachromosomal recombination of the c-myc locus leading to gene amplification 27
Effects of Parietaria judaica pollen on human lung microvascular endothelial cells 27
Il polimorfismo S128R dell'E-Selectina: analisi genotipica e caratterizzazione funzionale nell'interazione cellula tumorale-endotelio 27
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations 26
Due differenti meccanismi molecolari coinvolti nel fenomeno dell'amplificazione genica in un caso di carcinoma colorettale 26
Analysis of cellular signalling and proteomic profiling in Imatinib-resistant chronic myeloid leucemia cells following treatment with carboxyamidotriazole 26
Identification of a novel and recurrent mutation in the SERPING1 gene in patients with hereditary angioedema. 26
Severe hypertrophic cardiomyopathy in a patient with atypical Anderson-Fabry disease. 26
Comparative study of T84 and T84SF human colon carcinoma cells: in vitro and in vivo ultrastructural and functional characterization of cell culture and metastasis 26
Identification of biomarkers in cerebrospinal fluid and serum of multiple sclerosis patients by immunoproteomics approach 26
Identificazione ed analisi di complessi proteici nei sieri di pazienti affetti da sclerosi multipla 25
Ruolo di H-RAS e K-RAS nell'espressione di mucine nel carcinoma colorettale 25
Amplificazione e riarrangiamento nei tumori colorettali 25
Identification of a novel mutation in patients with hereditary angioedema 24
Role of H-RAS and K-RAS oncogenes on mucin expression in colorectal carcinoma 24
Analisi del profilo dell'espressione genica delle cellule di carcinoma del colon umano T84 e T84SF: ruolo del pathway di AKT nel processo metastatico 24
Espressione di geni muc in cellule epiteliali umane normali e tumorali 24
Cytokine gene expression in the tunica albuginea of patients with Peyronie's disease. Pilot study with a control group 24
Role of S128R polymorphism of E-selectin in colon metastasis formation 23
Effetti sinergici dell'azione antitumorale dell'epigallocatechina-3-gallato in combinazione con il carbossiamido-triazolo, un inibitore dei canali del calcio voltaggio-indipendenti 23
Amplificazione e riarrangiamento nei tumori colorettali 23
Studio degli effetti di Imatinib mesilato e CAI su linee cellulari di leucemia mieloide cronica resistenti all'Imatinib mesilato 23
Effetti dell'estratto proteico del polline di Parietaria judaica su cellule endoteliali della microvascolatura polmonare 23
Role of E-selectin in the modulation of metastatic phenotype 23
Antiproteinuric effect of add-on paricalcitol in Fabry disease patients: a prospective observational study. 22
Effects of different RAS mutations on colorectal cancer cells 21
Effects of carboxyamidotriazole on in vitro models of imatinib-resistant chronic myeloid leukemia 21
Characterization of transfected HT-29 cells expressing the oncogenic Ras isoform K-rasG13D 19
Modulation of the MUC1 and MUC2 promoter activity by RAS isoforms 18
Overcoming Imatinib resistance using CAI, a calcium-mediated signal transduction inhibitor: a new therapeutic strategy for chronic myelogenous leukaemia 16
New p65 iso5 isoforms as dexamethasone-binding proteins: novel potential therapeutic targets for inflammatory diseases 11
Epigenetic modulation of the gut-muscle axis in pompe disease: Microbiota fingerprints to cellular and molecular pathomechanisms 3
Totale 3.929
Categoria #
all - tutte 12.189
article - articoli 9.222
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.411


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202419 0 0 0 0 0 0 0 0 6 0 12 1
2024/20251.572 71 8 93 38 381 55 4 116 95 106 330 275
2025/20262.338 106 171 188 346 431 108 300 97 123 224 211 33
Totale 3.929